Early assessment of treatment response in primary biliary cholangitis: key to timely management
The assessment of treatment response at month 6 is very accurate predictor of complete biochemical response throughout the course of the disease. For non-responders to UDCA treatment, the addition of second line PBC treatment is indicated. For patients who have not met Toronto criteria at month 6 of UDCA treatment, the addition of second line PBC therapy should be considered.
Authors
- Tomáš Koky
- Peter Jarčuška (ORCID: https://orcid.org/0000-0001-6169-9984)
- Sylvia Dražilová (ORCID: https://orcid.org/0000-0003-2448-6757)
- Jakub Gazda (ORCID: https://orcid.org/0000-0003-2246-2217)
- Martin Janíčko (ORCID: https://orcid.org/0000-0002-3329-3968)
- Dominika Toporcerová
Institutions
- University of Pavol Jozef Šafárik (SK)
- Fires (Slovakia) (SK)
- Univerzitná Nemocnica Louisa Pasteura (SK)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1186/s12876-025-04138-w
- Citations
- 2
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 2.64